BRCA2 and breast carcinoma: Despite these differences in familial phenotype, the majority of families present only early onset breast cancer and there is little to indicate which gene should be targeted first for more efficient mutation screening or if in fact one of the BRCA1 or BRCA2 gene is at cause.